Psychiatry and Neurology, Neurology · Cleveland, OH
NPI
1720318355
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9500 Euclid Avenue, Desk U10, Cleveland Clinic
Cleveland, OH, 44195
Phone (216) 444-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
3,011 services
Medicare patients, 2024
146
Average age 68
Drug cost, 2024
$1.6M
647 prescriptions
Company payments, 2025
$53K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hesham A Abboud was code 99213 (office e&m - established), 37 times for 32 patients. In total Hesham A Abboud billed 3,011 services in 25 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 37 | 32 | $41.49 | $1,535 |
| 99205 Office E&M - New | Facility | 30 | 30 | $110.84 | $3,325 |
| 99233 Hospital E&M - Subsequent | Facility | 29 | 13 | $75.77 | $2,197 |
| 99214 Office E&M - Established | Office | 28 | 18 | $93.05 | $2,605 |
| 99215 Office E&M - Established | Facility | 26 | 21 | $102.02 | $2,653 |
| 99214 Office E&M - Established | Facility | 21 | 20 | $69.87 | $1,467 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $124.63 | $1,994 |
By year: 2022 $79K for 11,271 services; 2023 $81K for 12,411 services; 2024 $38K for 3,011 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hesham A Abboud prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 118 prescriptions and refills. In total Hesham A Abboud wrote 647 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 118 | 246 | 37 | $2,918 |
| Baclofen Generic | 60 | 102 | 25 | $1,829 |
| Kesimpta Pen Ofatumumab | 41 | 41 | Under 11 | $390K |
| Gabapentin Generic | 37 | 57 | 11 | $779 |
| Tizanidine Hcl Generic | 32 | 48 | Under 11 | $206 |
| Primidone Generic | 25 | 57 | Under 11 | $411 |
| Enspryng Satralizumab-Mwge | 24 | 29 | Under 11 | $517K |
| Mycophenolate Mofetil Generic | 18 | 26 | Under 11 | $2,428 |
| Zeposia Ozanimod Hydrochloride | 18 | 24 | Under 11 | $210K |
| Dalfampridine Er Dalfampridine | 17 | 17 | Under 11 | $2,987 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 14 | 32 | Under 11 | $352 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 13 | 25 | Under 11 | $90.06 |
| Dantrolene Sodium Generic | 12 | 12 | Under 11 | $890 |
| Topiramate Generic | 11 | 27 | Under 11 | $199 |
Brand drugs: 135 claims; generic drugs: 512 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hesham A Abboud $53K ($42K in general payments such as food, travel and fees and $11K for research) from 14 companies. The largest payer was Genentech USA, Inc. with $24K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.